Summary: Frontotemporal dementia (FTD), a common form of early-onset dementia, is often misdiagnosed due to its overlapping symptoms with psychiatric and neurological disorders. In a new NIH-funded study, researchers identified key protein changes in spinal fluid that may serve as the first specific biomarkers for FTD in living patients.
These proteins point to problems in RNA regulation and neural connectivity, both crucial for healthy brain function. By analyzing inherited cases of FTD, researchers hope to develop earlier diagnostic tools that can direct patients into appropriate treatments and clinical trials.
Key Facts:
- Early Clues Identified: Over 4,000 proteins analyzed revealed changes specific to FTD.
- Biological Mechanisms: Altered RNA regulation and brain connectivity may drive the disease.
- Diagnostic Hope:…